{"transactions":[{"id":689444,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option, which was granted on May 3, 2023, were fully vested."}],"balance_after":46500,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":689443,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":12300,"price":11.2502,"value":138377.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.23 to $11.31. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":689442,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:16:04.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":12300,"price":4.97,"value":61131.0,"ownership":{"direct":true},"balance_after":14100,"source":{"system":"sec-edgar","filing":"0001434647-26-000070","document":"wk-form4_1786565760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000070/wk-form4_1786565760.xml","form_type":"4"}},{"id":732363,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:01.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000053","document":"wk-form4_1781813758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143464726000053/wk-form4_1781813758.xml","form_type":"4"}},{"id":1129503,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:38:48.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019046","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774925019046/rdgdoc.xml","form_type":"4"}},{"id":1188072,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-01T00:05:01.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":7.8384,"value":2351.52,"ownership":{"direct":true},"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001437749-25-010332","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774925010332/rdgdoc.xml","form_type":"4"}},{"id":1385985,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-16T20:46:26.000Z","date":"2024-10-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":7.9153,"value":3957.65,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001437749-24-031367","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774924031367/rdgdoc.xml","form_type":"4"}},{"id":1516204,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:15:39.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-24-017180","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774924017180/rdgdoc.xml","form_type":"4"}},{"id":1844416,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-26T20:19:26.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":275,"price":5.9479,"value":1635.6725,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001437749-23-018447","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774923018447/rdgdoc.xml","form_type":"4"}},{"id":1857491,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-14T00:35:20.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":325,"price":5.52,"value":1794.0,"ownership":{"direct":true},"balance_after":725,"source":{"system":"sec-edgar","filing":"0001437749-23-017335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774923017335/rdgdoc.xml","form_type":"4"}},{"id":1873518,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-31T15:34:07.000Z","date":"2023-05-30","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":5.1053,"value":2042.12,"ownership":{"direct":true},"balance_after":400,"source":{"system":"sec-edgar","filing":"0001437749-23-016221","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774923016221/rdgdoc.xml","form_type":"4"}},{"id":1901141,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":24200,"kind":"person","name":"Watton Corey Michael","position":1,"cik":"0001975404","reported_name":"Watton Corey Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:55:35.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 3, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":58800,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001437749-23-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975404/000143774923013127/rdgdoc.xml","form_type":"4"}}]}